Is BDRX or BIVI more undervalued in 2026?

CirclFi compares Biodexa Pharmaceuticals plc (BDRX) and BioVie Inc. (BIVI) using 13 institutional-grade valuation models. BDRX has a Quality of Company score of 1.7/10 while BIVI scores 3.2/10.

Which is a better buy — BDRX or BIVI?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BDRX and BIVI valuations compare?

BDRX at $3.36 and BIVI at $1.44 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BDRX vs BIVI Valuation Comparison 2026 — Intrinsic Value Analysis

BDRX

Biotechnology

Biodexa Pharmaceuticals plc

Quality

1.7

out of 10

Value Trap

—

Price

$3.36

Last close

Models

6/13

Active

BIVI

Biotechnology

BioVie Inc.

Quality

3.2

out of 10

Value Trap

LOW

Price

$1.44

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	BDRX Fair Value	BDRX Upside	BIVI Fair Value	BIVI Upside
Bayesian DCF	Intrinsic	$0.89	-73.5%	$1.46	+1.2%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$3.04	-7.9%	$0.27	-84.1%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BDRX vs BIVI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BDRX vs BIVI — Which Stock Is More Undervalued?

BIVI scores higher with a 3.2/10 quality rating vs BDRX's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Biodexa Pharmaceuticals plc (BDRX) and BioVie Inc. (BIVI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BDRX currently trades at $3.36 with a QOC of 1.7/10, while BIVI trades at $1.44 with a QOC of 3.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).